Comparing Genetic Testing Models for Hereditary Cancer Syndrome
This study is comparing two ways to offer genetic testing for hereditary cancer syndromes (conditions that increase your risk of cancer and can be passed down in families) in community health centers. Researchers want to see if the "Mainstream Genetic Testing Model" or the "Enhanced Standard of Care Model" is better at getting more people to get tested. You may be able to join if you are an adult aged 25 or older, speak English, and have been identified as potentially needing genetic testing for hereditary breast or colon cancer (like for BRCA or Lynch syndrome). The main goal is to see how many people get genetic testing within two years. The current recruitment status is unclear.
- Study design
- This study is an interventional trial with a planned enrollment of 80 participants. It uses a randomized design to compare two different approaches to genetic testing.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal of the study is measured at 2 years, which suggests a follow-up period of at least that long.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation of Population Cancer Genetic Services in Federally Qualified Health Centers (FQHC)
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Uptake of genetic testing2 years
compare the uptake of genetic testing among patients in both models of cancer genetic delivery who screen positive on hereditary cancer risk asserssment (HCRA)